BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30022812)

  • 21. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.
    Parker RB; Yates CR; Soberman JE; Laizure SC
    Pharmacotherapy; 2003 Aug; 23(8):979-87. PubMed ID: 12921244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosis.
    Veerman GDM; van der Werff SC; Koolen SLW; Miedema JR; Oomen-de Hoop E; van der Mark SC; Chandoesing PP; de Bruijn P; Wijsenbeek MS; Mathijssen RHJ
    Biomed Pharmacother; 2022 Jul; 151():113101. PubMed ID: 35594703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant use of tea catechins affects absorption and serum triglyceride-lowering effects of monoglucosyl hesperidin.
    Katada S; Oishi S; Yanagawa K; Ishii S; Oki M; Matsui Y; Osaki N; Takano K; Hibi M
    Food Funct; 2021 Oct; 12(19):9339-9346. PubMed ID: 34606551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo and in vivo investigations of the effects of extracts of Vernonia amygdalina, Carica papaya and Tapinanthus sessilifolius on digoxin transport and pharmacokinetics: assessing the significance on rat intestinal P-glycoprotein efflux.
    Oga EF; Sekine S; Horie T
    Drug Metab Pharmacokinet; 2013; 28(4):314-20. PubMed ID: 23291634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
    Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinations of common SNPs of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxin.
    Hsin CH; Stoffel MS; Gazzaz M; Schaeffeler E; Schwab M; Fuhr U; Taubert M
    Sci Rep; 2020 Jul; 10(1):12457. PubMed ID: 32719417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin.
    Ling SY; Huizinga RB; Mayo PR; Larouche R; Freitag DG; Aspeslet LJ; Foster RT
    Br J Clin Pharmacol; 2014 Jun; 77(6):1039-50. PubMed ID: 24330024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of green tea catechins on oxidative stress metabolites at rest and during exercise in healthy humans.
    Sugita M; Kapoor MP; Nishimura A; Okubo T
    Nutrition; 2016 Mar; 32(3):321-31. PubMed ID: 26695876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 28-Day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats.
    Chengelis CP; Kirkpatrick JB; Regan KS; Radovsky AE; Beck MJ; Morita O; Tamaki Y; Suzuki H
    Food Chem Toxicol; 2008 Mar; 46(3):978-89. PubMed ID: 18086511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical Studies.
    Martin P; Gillen M; Millson D; Oliver S; Brealey C; Elsby R; Baluom M; Lau D; Mant T
    Clin Ther; 2015 Dec; 37(12):2811-22. PubMed ID: 26514315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
    Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
    Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety assessment of heat-sterilized green tea catechin preparation: a 6-month repeat-dose study in rats.
    Morita O; Kirkpatrick JB; Tamaki Y; Chengelis CP; Beck MJ; Bruner RH
    Food Chem Toxicol; 2009 Aug; 47(8):1760-70. PubMed ID: 19406200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers.
    Misaka S; Ono Y; Uchida A; Ono T; Abe O; Ogata H; Sato H; Suzuki M; Onoue S; Shikama Y; Shimomura K
    Clin Transl Sci; 2021 Mar; 14(2):476-480. PubMed ID: 33048477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of tea catechin-rich beverages to reduce abdominal adiposity and metabolic syndrome risks in obese and overweight subjects: a pooled analysis of 6 human trials.
    Hibi M; Takase H; Iwasaki M; Osaki N; Katsuragi Y
    Nutr Res; 2018 Jul; 55():1-10. PubMed ID: 29914623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of reduced P-glycoprotein function on digoxin concentrations in patients with dementia.
    Ali I; Guidone D; Nicolazzo JA; Brouwer KLR
    Br J Clin Pharmacol; 2019 Oct; 85(10):2351-2359. PubMed ID: 31269278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
    Becquemont L; Glaeser H; Drescher S; Hitzl M; Simon N; Murdter TE; Heinkele G; Hofmann U; Schaefer C; Burk O; Verstuyft C; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2006 May; 79(5):449-60. PubMed ID: 16678547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Stereochemical Configuration on the Transport and Metabolism of Catechins from Green Tea across Caco-2 Monolayers.
    Ai Z; Liu S; Qu F; Zhang H; Chen Y; Ni D
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30917581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
    Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
    Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.
    Cawello W; Mueller-Voessing C; Andreas JO
    Clin Drug Investig; 2014 May; 34(5):327-34. PubMed ID: 24634110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.